A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr
NCT05519670
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Niraparib Oral Product
Sponsor
Institut Paoli-Calmettes
Collaborators
[object Object]